Dr. Soldatov joined the Computational Oncology Service at Memorial Sloan Kettering Cancer Center (MSK) in 2022 as an Assistant Attending. Dr. Soldatov’s research seeks to characterize the mechanisms of cell fate decisions that coordinate tissue function and quantify how distortions of these mechanisms shape the course of cancer evolution. He develops computational methods to analyze high-throughput measurements at the single-cell resolution, including multi-omics and lineage data.
Dr. Soldatov received a PhD in computational biology from the Institute for Information Transmission Problems in Moscow and trained as a postdoctoral fellow at Harvard Medical School with Dr. Peter Kharchenko. Before joining MSK, he was an Instructor in Biomedical Informatics at Harvard Medical School. Dr. Soldatov has authored many publications in high-ranking journals.